| Octapharma AG - Cutaquig 165 mg/ml, Injektionslösung |
| 68222 | | 01 | | Cutaquig 165 mg/ml | | Injektionslösung | | J06BA01 | | Immunglobuline, normal human, zur extravasalen Anwendung | | 15.02.2022 | | |
|
| Composition |
| immunoglobulinum humanum normale 165 mg, maltosum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Immunoglobulinum Humanum Normale | 165 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Immunoglobulinum Humanum Normale | 7920 mg |
| | | | Agents auxilliaires |
|---|
| Maltosum | | Polysorbatum 80 |
| |
|
|
